Replies to post #60538 on Ayala Pharmaceuticals Inc (ADXS)

[fbg0316]

Yea, but if management can't monetize anything and is poor steward of our capital as they have been, we will continue to see the same thing because they still get the same salary (actually they just have themselves raises) even though they decked us with a $2 raise. Our best ever cervical trial was completed in 2014/2015 but O'Connor said he was going to hold our licensing our core markets (US and EU) until later to command a bigger deal. Now, years later, according to Bourbon, TL implied at the meeting there is not a lot of demand for AXAL because it's an older orphan construct. Just sad seeing all the wasted money, poor strategy not monetizing AXAL earlier like ADURO and the greed and unethical things DOC to pay himself unearned comp at our expense.